Publications by authors named "Robert Leshner"

Claim this Profile
C
Clinical, genetic, and pathologic characterization of Mexican founder mutation c.1387A>G.
Angela J Lee, Karra A Jones, Russell J Butterfield, Mary O Cox, Chamindra G Konersman, Robert T Leshner

Neurol Genet· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies.
Christopher F Spurney, Francis M McCaffrey, Avital Cnaan, Lauren P Morgenroth, Sunil J Ghelani, Robert T Leshner

J Am Soc Echocardiogr· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The quick motor function test: a new tool to rate clinical severity and motor function in Pompe patients.
Carine I van Capelle, Nadine A M E van der Beek, Juna M de Vries, Pieter A van Doorn, Hugo J Duivenvoorden, Robert T Leshner

J Inherit Metab Dis· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus treatment recommendations for late-onset Pompe disease.
Edward J Cupler, Kenneth I Berger, Robert T Leshner, Gil I Wolfe, Jay J Han

Muscle Nerve· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral therapy-associated acute motor and sensory axonal neuropathy.
Kimberly N Capers, Sinan Turnacioglu, Robert T Leshner, John R Crawford

Case Rep Neurol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized study of alglucosidase alfa in late-onset Pompe's disease.
Ans T van der Ploeg, Paula R Clemens, Deyanira Corzo, Diana M Escolar, Julaine Florence, Robert T Leshner

N Engl J Med· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy.
Bakri Elsheikh, Thomas Prior, Xiaoli Zhang, Robert Miller, Stephen J Kolb, Robert Leshner

Muscle Nerve· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated cranial nerve enhancement in metachromatic leukodystrophy.
Rani K Singh, Robert T Leshner, Nadja Kadom, Adeline L Vanderver

Pediatr Neurol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CINRG pilot trial of oxatomide in steroid-naïve Duchenne muscular dystrophy.
Gunnar M Buyse, Nathalie Goemans, Erik Henricson, Alejandro Jara, Marleen van den Hauwe, Robert Leshner

Eur J Paediatr Neurol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy.
Jill E Mayhew, Julaine M Florence, Thomas P Mayhew, Erik K Henricson, Robert T Leshner

Muscle Nerve· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype-phenotype correlations in hereditary muscle diseases. Implications for diagnosis and treatment.
Robert T Leshner

Suppl Clin Neurophysiol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.
Diana M Escolar, Gunnar Buyse, Erik Henricson, Robert Leshner, Julaine Florence

Ann Neurol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory failure as a first presentation of myasthenia gravis.
Adnan I Qureshi, Mohammad A Choundry, Yousef Mohammad, Hoe C Chua, Abutaher M Yahia, Robert T Leshner

Med Sci Monit· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis